TY - JOUR
T1 - Perspective
T2 - Cancer Patient Management Challenges During the COVID-19 Pandemic
AU - Terracciano, Daniela
AU - Buonerba, Carlo
AU - Scafuri, Luca
AU - De Berardinis, Piergiuseppe
AU - Calin, George A.
AU - Ferrajoli, Alessandra
AU - Fabbri, Muller
AU - Cimmino, Amelia
N1 - Publisher Copyright:
© Copyright © 2020 Terracciano, Buonerba, Scafuri, De Berardinis, Calin, Ferrajoli, Fabbri and Cimmino.
PY - 2020/8/18
Y1 - 2020/8/18
N2 - On March 11, 2020, the WHO has declared the coronavirus disease 2019 (COVID-19) a global pandemic. As the last few months have profoundly changed the delivery of health care in the world, we should recognize the effort of numerous comprehensive cancer centers to share experiences and knowledge to develop best practices to care for oncological patients during the COVID-19 pandemic. Patients as well as physicians must be aware of all these constraints and profound social, personal, and medical challenges posed by the tackling of this deadly disease in everyday life in order to adjust to such a completely novel scenario. This review will discuss facing the challenges and the current approaches that cancer centers in Italy and United States are adopting in order to cope with clinical and research activities.
AB - On March 11, 2020, the WHO has declared the coronavirus disease 2019 (COVID-19) a global pandemic. As the last few months have profoundly changed the delivery of health care in the world, we should recognize the effort of numerous comprehensive cancer centers to share experiences and knowledge to develop best practices to care for oncological patients during the COVID-19 pandemic. Patients as well as physicians must be aware of all these constraints and profound social, personal, and medical challenges posed by the tackling of this deadly disease in everyday life in order to adjust to such a completely novel scenario. This review will discuss facing the challenges and the current approaches that cancer centers in Italy and United States are adopting in order to cope with clinical and research activities.
KW - cancer
KW - chemotherapy
KW - coronavirus disease 2019 (COVID-19)
KW - pandemic
KW - severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
UR - http://www.scopus.com/inward/record.url?scp=85090929869&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85090929869&partnerID=8YFLogxK
U2 - 10.3389/fonc.2020.01556
DO - 10.3389/fonc.2020.01556
M3 - Article
C2 - 32984015
AN - SCOPUS:85090929869
SN - 2234-943X
VL - 10
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 1556
ER -